KVLQF yields 2857.14% · JNJ yields 2.13%● Live data
📍 KVLQF pulled ahead of the other in Year 1
Combined, KVLQF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KVLQF + JNJ for your $10,000?
ValOre Metals Corp., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral resource properties in Canada and Brazil. The company explores for uranium, palladium, platinum, and gold deposits. It holds 100% interests in the Angilak Property that covers an area of 29,595.57 hectares and the Baffin Gold Property that covers an area of 352,727.87 hectares located in Nunavut Territory; the Hatchet Lake Property that consists of 6 claims covering an area of 13,711 hectares located in Saskatchewan; and the Pedra Branca Project that includes 38 exploration licenses covering an area of 38,940 hectares located in north-eastern Brazil. The company was formerly known as Kivalliq Energy Corporation and changed its name to ValOre Metals Corp. in June 2018. ValOre Metals Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.
Full KVLQF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.